Quality of diabetes care among patients with schizophrenia. A mixed-methods study

Objectives: Patients with schizophrenia are at high risk of developing diabetes. Our study aimed to determine the prevalence of diabetes in patients with schizophrenia and assess their quality of diabetes care. We further aimed to explore the factors affecting diabetes care in patients with schizoph...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Nouf M. Aloudah, Hanan Almanea, Khloud Alotaibi, Khalid A. Al Rubeaan
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Health services research Schizophrenia Diabetes care Implementation research Quality improvement Diabetes Pharmacy and materia medica RS1-441
Acceso en línea:	https://doaj.org/article/a6460469cd1247b9b26ff4bad432bf03
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:a6460469cd1247b9b26ff4bad432bf03
record_format	dspace
spelling	oai:doaj.org-article:a6460469cd1247b9b26ff4bad432bf032021-11-28T04:39:55ZQuality of diabetes care among patients with schizophrenia. A mixed-methods study2667-276610.1016/j.rcsop.2021.100070https://doaj.org/article/a6460469cd1247b9b26ff4bad432bf032021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2667276621000706https://doaj.org/toc/2667-2766Objectives: Patients with schizophrenia are at high risk of developing diabetes. Our study aimed to determine the prevalence of diabetes in patients with schizophrenia and assess their quality of diabetes care. We further aimed to explore the factors affecting diabetes care in patients with schizophrenia. Research design and methods: We conducted a retrospective review of medical records for patients presenting with schizophrenia from October 2017 to October 2018. Thereafter, we conducted semi-structured interviews based on the Theoretical Domains Framework to explore healthcare providers' attitudes and perspectives toward diabetes care in patients with schizophrenia at a tertiary hospital for mental health services in Saudi Arabia. Results: The prevalence of diabetes in patients with schizophrenia was 3.7%. The rates of annual testing for quality indicators of diabetes were 8.6% for HgbA1c and 31.4% for low-density lipoprotein cholesterol (LDL-C). Screenings for albuminuria and examinations of the eyes and feet were not conducted. Documentation of smoking status was done infrequently (8.6%). The in-depth interviews uncovered issues with managing diabetes in patients with schizophrenia. We identified four themes: the consequences of poor quality diabetic care provided to patients with schizophrenia; problems with the identification of diabetes in patients with schizophrenia; challenges in the management of patients with both diabetes and schizophrenia; and opportunities to improve the quality of diabetes care provided to patients with schizophrenia. Conclusions: This study identified areas that need a considerable amount of work to be undertaken in Saudi Arabia to help patients with schizophrenia. There are numerous opportunities for improving the quality of Type 2 diabetes care such as the involvement of pharmacists to effectively manage diabetes and expanding community-based health services to include mental health, which could accelerate improved care services.Nouf M. AloudahHanan AlmaneaKhloud AlotaibiKhalid A. Al RubeaanElsevierarticleHealth services researchSchizophreniaDiabetes careImplementation researchQuality improvementDiabetesPharmacy and materia medicaRS1-441ENExploratory Research in Clinical and Social Pharmacy, Vol 4, Iss , Pp 100070- (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Health services research Schizophrenia Diabetes care Implementation research Quality improvement Diabetes Pharmacy and materia medica RS1-441
spellingShingle	Health services research Schizophrenia Diabetes care Implementation research Quality improvement Diabetes Pharmacy and materia medica RS1-441 Nouf M. Aloudah Hanan Almanea Khloud Alotaibi Khalid A. Al Rubeaan Quality of diabetes care among patients with schizophrenia. A mixed-methods study
description	Objectives: Patients with schizophrenia are at high risk of developing diabetes. Our study aimed to determine the prevalence of diabetes in patients with schizophrenia and assess their quality of diabetes care. We further aimed to explore the factors affecting diabetes care in patients with schizophrenia. Research design and methods: We conducted a retrospective review of medical records for patients presenting with schizophrenia from October 2017 to October 2018. Thereafter, we conducted semi-structured interviews based on the Theoretical Domains Framework to explore healthcare providers' attitudes and perspectives toward diabetes care in patients with schizophrenia at a tertiary hospital for mental health services in Saudi Arabia. Results: The prevalence of diabetes in patients with schizophrenia was 3.7%. The rates of annual testing for quality indicators of diabetes were 8.6% for HgbA1c and 31.4% for low-density lipoprotein cholesterol (LDL-C). Screenings for albuminuria and examinations of the eyes and feet were not conducted. Documentation of smoking status was done infrequently (8.6%). The in-depth interviews uncovered issues with managing diabetes in patients with schizophrenia. We identified four themes: the consequences of poor quality diabetic care provided to patients with schizophrenia; problems with the identification of diabetes in patients with schizophrenia; challenges in the management of patients with both diabetes and schizophrenia; and opportunities to improve the quality of diabetes care provided to patients with schizophrenia. Conclusions: This study identified areas that need a considerable amount of work to be undertaken in Saudi Arabia to help patients with schizophrenia. There are numerous opportunities for improving the quality of Type 2 diabetes care such as the involvement of pharmacists to effectively manage diabetes and expanding community-based health services to include mental health, which could accelerate improved care services.
format	article
author	Nouf M. Aloudah Hanan Almanea Khloud Alotaibi Khalid A. Al Rubeaan
author_facet	Nouf M. Aloudah Hanan Almanea Khloud Alotaibi Khalid A. Al Rubeaan
author_sort	Nouf M. Aloudah
title	Quality of diabetes care among patients with schizophrenia. A mixed-methods study
title_short	Quality of diabetes care among patients with schizophrenia. A mixed-methods study
title_full	Quality of diabetes care among patients with schizophrenia. A mixed-methods study
title_fullStr	Quality of diabetes care among patients with schizophrenia. A mixed-methods study
title_full_unstemmed	Quality of diabetes care among patients with schizophrenia. A mixed-methods study
title_sort	quality of diabetes care among patients with schizophrenia. a mixed-methods study
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/a6460469cd1247b9b26ff4bad432bf03
work_keys_str_mv	AT noufmaloudah qualityofdiabetescareamongpatientswithschizophreniaamixedmethodsstudy AT hananalmanea qualityofdiabetescareamongpatientswithschizophreniaamixedmethodsstudy AT khloudalotaibi qualityofdiabetescareamongpatientswithschizophreniaamixedmethodsstudy AT khalidaalrubeaan qualityofdiabetescareamongpatientswithschizophreniaamixedmethodsstudy
_version_	1718408276873314304

Quality of diabetes care among patients with schizophrenia. A mixed-methods study

Ejemplares similares